VALIDATION OF CHOLERA IN VOLUNTEERS USING FROZEN BACTERIA FOR CHALLENGE
使用冷冻细菌进行挑战的志愿者中霍乱的验证
基本信息
- 批准号:6245486
- 负责人:
- 金额:$ 2.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-03-05 至 1997-11-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Five healthy adult community volunteers participated in a virulent cholera
challenge study at the Johns Hopkins University Vaccine Testing Unit with
challenge occurring on September 10. This is the fourth group tested with
this challenge at the VTU and the third receiving a dose of 5 logs. The
inoculum of 9.9 X 10 4 was prepared and administered. Four of five
volunteers developed diarrhea during the study, and all were managed with
rehydration fluids. Three of the volunteers developed a fever. Four of 5
volunteers had stools repeatedly positive for V cholerae during days 1 to
4, but the stool cultures became negative for v. cholerae within one - two
days of starting tetracycline. One did not have a stool during the study
so only rectal swabs were cultured and these were negative. This
volunteer also developed pruritis shortly after starting tetracycline and
was switched to ciprofloxacin.
五名健康成人社区志愿者参与了一场致命的霍乱
约翰·霍普金斯大学疫苗测试中心的挑战研究
挑战发生在 9 月 10 日。这是第四组接受测试的
这次挑战是在 VTU 进行的,第三次挑战接受了 5 log 的剂量。 这
制备并施用9.9×10 4 的接种物。 五之四
志愿者在研究期间出现腹泻,所有志愿者都接受了治疗
补液。三名志愿者出现发烧症状。 5 个中的 4 个
志愿者在第 1 天至第 1 天期间粪便中反复出现霍乱弧菌阳性
4,但一到两秒内粪便培养物霍乱弧菌呈阴性
开始使用四环素的天数。 研究期间没有大便
因此只进行了直肠拭子培养,结果呈阴性。 这
志愿者在开始四环素治疗后不久也出现瘙痒症
改用环丙沙星。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID A SACK其他文献
DAVID A SACK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID A SACK', 18)}}的其他基金
A cross protective multivalent vaccine for Shigella and ETEC
针对志贺氏菌和 ETEC 的交叉保护性多价疫苗
- 批准号:
10633470 - 财政年份:2023
- 资助金额:
$ 2.23万 - 项目类别:
A broadly protective vaccine for enterotoxigenic Escherichia coli (ETEC)
针对产肠毒素大肠杆菌 (ETEC) 的广泛保护性疫苗
- 批准号:
8700783 - 财政年份:2013
- 资助金额:
$ 2.23万 - 项目类别:
PHASE I, DOSE ESCALATION, SAFETY & ENTEROTOXIGENIC E COLI
第一阶段,剂量递增,安全性
- 批准号:
6264081 - 财政年份:1998
- 资助金额:
$ 2.23万 - 项目类别:
PHASE I, DOSE ESCALATION, SAFETY & ENTEROTOXIGENIC E COLI
第一阶段,剂量递增,安全性
- 批准号:
6297468 - 财政年份:1998
- 资助金额:
$ 2.23万 - 项目类别:
Epidemiology and Ecology of Vibrio cholerae in Bangladesh
孟加拉国霍乱弧菌的流行病学和生态学
- 批准号:
8090286 - 财政年份:1996
- 资助金额:
$ 2.23万 - 项目类别:
Epidemiology and Ecology of Vibrio cholerae in Bangladesh
孟加拉国霍乱弧菌的流行病学和生态学
- 批准号:
8662678 - 财政年份:1996
- 资助金额:
$ 2.23万 - 项目类别:
IMPROVED LABORATORY DIAGNOSIS OF DIARRHOEAGENIC E.COLI A
改进腹泻性大肠杆菌 A 的实验室诊断
- 批准号:
3422658 - 财政年份:1991
- 资助金额:
$ 2.23万 - 项目类别:
相似海外基金
Development of rapid detection method for drug-resistant bacteria in pulmonary MAC disease and search for new antibacterial agents
肺部MAC疾病耐药菌快速检测方法的建立及新型抗菌药物的寻找
- 批准号:
23K07930 - 财政年份:2023
- 资助金额:
$ 2.23万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of novel antibacterial agents using crystal structure-based drug screening
利用基于晶体结构的药物筛选开发新型抗菌剂
- 批准号:
23K07918 - 财政年份:2023
- 资助金额:
$ 2.23万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
ATP Synthase as an emerging target for the pre-clinical development of broad-spectrum antibacterial agents against drug-resistant bacterial infections
ATP 合酶作为针对耐药细菌感染的广谱抗菌药物临床前开发的新兴靶标
- 批准号:
472342 - 财政年份:2022
- 资助金额:
$ 2.23万 - 项目类别:
Operating Grants
Clinical application of a rapid assay for antibacterial susceptibility test of beta-lactams and carbapenems antibacterial agents using MALDI-TOF MS
MALDI-TOF MS快速测定β-内酰胺类和碳青霉烯类抗菌药物药敏试验的临床应用
- 批准号:
22K07406 - 财政年份:2022
- 资助金额:
$ 2.23万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Tailored and uniform fibre-like micelles as antibacterial agents.
定制且均匀的纤维状胶束作为抗菌剂。
- 批准号:
569719-2022 - 财政年份:2022
- 资助金额:
$ 2.23万 - 项目类别:
Postgraduate Scholarships - Doctoral
Development of pH-responsive carriers for the controlled release of encapsulated acidifying and antibacterial agents
开发用于控制释放封装酸化剂和抗菌剂的 pH 响应载体
- 批准号:
531450-2018 - 财政年份:2022
- 资助金额:
$ 2.23万 - 项目类别:
Collaborative Research and Development Grants
Novel silver nanoparticles as antibacterial agents
作为抗菌剂的新型银纳米颗粒
- 批准号:
521908-2018 - 财政年份:2021
- 资助金额:
$ 2.23万 - 项目类别:
Collaborative Research and Development Grants
Development of pH-responsive carriers for the controlled release of encapsulated acidifying and antibacterial agents
开发用于控制释放封装酸化剂和抗菌剂的 pH 响应载体
- 批准号:
531450-2018 - 财政年份:2021
- 资助金额:
$ 2.23万 - 项目类别:
Collaborative Research and Development Grants
Novel silver nanoparticles as antibacterial agents
作为抗菌剂的新型银纳米颗粒
- 批准号:
521908-2018 - 财政年份:2020
- 资助金额:
$ 2.23万 - 项目类别:
Collaborative Research and Development Grants
Development of pH-responsive carriers for the controlled release of encapsulated acidifying and antibacterial agents.
开发用于控制释放封装酸化剂和抗菌剂的 pH 响应载体。
- 批准号:
531450-2018 - 财政年份:2020
- 资助金额:
$ 2.23万 - 项目类别:
Collaborative Research and Development Grants














{{item.name}}会员




